Overview of FDA-Authorized VUSE E-Cigarette Products

The U.S. Food and Drug Administration (FDA) has granted marketing authorization to RJ Reynolds Vapor Company for an expanded range of Vuse e-cigarette products. This decision, announced on July 18, adds seven new Vuse Alto e-cigarette products to the company’s growing portfolio of FDA-approved offerings. RJ Reynolds Vapor Company, an American subsidiary of British American Tobacco, now boasts the largest portfolio of authorized e-cigarette products in the U.S. market.

1721368703 FDA has authorized 34 e cigarette products

Also Read:
FDA AUTHORIZES 6 VUSE ALTO TOBACCO-FLAVORED E-CIGARETTES

Vuse Alto: The Latest in FDA-Authorized E-Cigarettes

The Alto platform consists of the Vuse Alto Power Unit and six closed, pre-filled, and non-refillable Vuse Alto tobacco-flavored pods, utilizing FEELM ceramic coil technology.

Specification

Pod Capacity: 1.8 mL
Pods:
– Vuse Alto Pod Golden Tobacco 5% (5% nicotine strength)
– Vuse Alto Pod Rich Tobacco 5% (5% nicotine strength)
– Vuse Alto Pod Golden Tobacco 2.4% (2.4% nicotine strength)
– Vuse Alto Pod Rich Tobacco 2.4% (2.4% nicotine strength)
– Vuse Alto Pod Golden Tobacco 1.8% (1.8% nicotine strength)
– Vuse Alto Pod Rich Tobacco 1.8% (1.8% nicotine strength)
Battery Capacity: 350mAh Type-C rechargeable battery
Draw-activated system, activated without pressing a button

Previously Authorized Vuse Products

Vuse Vibe

The Vibe platform, granted FDA marketing authorization in October 2021, comprises the Vuse Vibe Power Unit (1), Vuse Vibe Power Unit (2), and Vuse Vibe Tank Original 3.0%.

Specification

Tank Capacity: 2mL
Tank: Vuse Vibe Tank Original 3.0% (3% nicotine strength)
Battery Capacity: 350mAh Type-C rechargeable battery
Features: LED indicator light

Vuse Ciro

The Vuse Ciro series received FDA marketing authorization in May 2022. It includes the Vuse Ciro Power Unit (1), Vuse Ciro Power Unit (2), and Vuse Ciro Cartridge Original 1.5%.

Specification

Cartridge Capacity: 0.9mL
Cartridge: Vuse Ciro Cartridge Original 1.5% (1.5% nicotine strength)
Battery Capacity: 260mAh Type-C rechargeable battery
Features: LED indicator light

Vuse Solo

Vuse Solo, granted FDA marketing authorization in October 2021, was the industry’s first electronic nicotine delivery system (ENDS) product to receive premarket tobacco product application (PMTA) clearance and enter the U.S. market. It consists of the Vuse Solo Power Unit, Vuse Replacement Cartridge Original 4.8% G1, and Vuse Replacement Cartridge Original 4.8% G2.

Specification

Cartridge Capacity: 1.2mL
Cartridges:
– Vuse Replacement Cartridge Original 4.8% G1 (4.8% nicotine strength)
– Vuse Replacement Cartridge Original 4.8% G2 (4.8% nicotine strength)
Battery Capacity: 250mAh Type-C rechargeable battery
Features: LED indicator light

Adhering to FDA Guidelines

All FDA-authorized Vuse products strictly adhere to a tobacco-only flavor profile, aligning with FDA restrictions on e-cigarette flavors. However, they offer a range of nicotine concentrations to cater to varying user preferences and needs.

Tadeu Marroco, CEO of British American Tobacco, highlighted the significance of this expanded portfolio, stating, “We currently have the largest portfolio of e-cigarette market authorizations available in the U.S., which will help us offer more potential reduced-risk product options to adult smokers.”

This development marks a crucial step in the e-cigarette industry’s evolution. Manufacturers continue to navigate regulatory requirements while addressing adult smokers’ needs for potentially less harmful alternatives to traditional cigarettes.

Also Read:
FDA AUTHORIZED E-CIGARETTE LIST: WHAT’S REALLY INCLUDED?

Author
Recent Posts

Matthew Ma

Marketing at Ecigator

With over a decade of experience in the e-cigarette industry, Matthew Ma is a seasoned expert in both the manufacturing and usage aspects of vaping products. His extensive background has provided him with a deep understanding of the intricacies and evolving dynamics of e-cigarettes.